Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diphtheria01:28

Diphtheria

16
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
16
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

3
Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
3
Atypical Pneumonia01:14

Atypical Pneumonia

2
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
2
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.2K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.2K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

2.1K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same author

Immunological insights into why pertussis continues to be endemic.

Human vaccines & immunotherapeutics·2026
Same author

Diagnostic performance and interchangeability of two commercial anti-RSV-IgG and IgA ELISAs across clinically relevant populations.

Microbiology spectrum·2026
Same author

Vaccination Against Serogroup B Meningococcal Disease: Current Status and Future Perspectives-A Consensus Document of the World Association for Infectious Diseases and Immunological Disorders (WAidid).

Vaccines·2026
Same author

Genome-wide association study of paediatric bacteraemia and sepsis.

EBioMedicine·2026
Same author

Review on pertussis case definitions: a need for reliable disease surveillance.

BMC infectious diseases·2026
Same journal

Morphotype-specific susceptibility to <i>Neosartorya</i> (<i>Aspergillus</i>) <i>fischeri</i> antifungal protein 2 is associated with an anabolic transcriptional signature in <i>Candida</i>.

Microbiology spectrum·2026
Same journal

High abundance of <i>Stenotrophomonas maltophilia</i> in slaty-backed gull breeding in Northern Japan.

Microbiology spectrum·2026
Same journal

Rhein reduces conjugation of IncFII-type plasmids in <i>Escherichia coli</i> and mitigates the spread of antibiotic resistance genes.

Microbiology spectrum·2026
Same journal

Phenotypic discordance in rifampicin resistance detection among <i>Mycobacterium tuberculosis</i> isolates from China: insights from whole-genome sequencing and a structured literature review.

Microbiology spectrum·2026
Same journal

Identification of protein secretion systems and type III effectors in wood-associated bacteria of the genus <i>Xylophilus</i>.

Microbiology spectrum·2026
Same journal

Intraspecific diversity of <i>Staphylococcus aureus</i> populations isolated from cystic fibrosis respiratory infections.

Microbiology spectrum·2026
See all related articles

Related Experiment Video

Updated: Mar 19, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.4K

Bordetella pertussis.

Delma J Nieves1, Ulrich Heininger2

  • 1Pediatric Infectious Diseases, CHOC Children's, Orange, CA 92868.

Microbiology Spectrum
|June 24, 2016
PubMed
Summary
This summary is machine-generated.

Protecting infants from pertussis (whooping cough) is crucial. Immunizing pregnant women is a cost-effective strategy to prevent infant illness and death from this highly infectious disease.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K
Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
08:03

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice

Published on: April 15, 2014

84.4K

Related Experiment Videos

Last Updated: Mar 19, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.4K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.7K
Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice
08:03

Myelin Oligodendrocyte Glycoprotein MOG35-55 Induced Experimental Autoimmune Encephalomyelitis EAE in C57BL/6 Mice

Published on: April 15, 2014

84.4K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Vaccinology

Background:

  • Pertussis (whooping cough) remains a significant global health concern, causing substantial morbidity and mortality.
  • Resurgence observed even in highly immunized populations, attributed to factors like bacterial evolution, waning immunity, and improved diagnostics.
  • Infants under three months are most vulnerable, experiencing severe illness and high mortality rates.

Purpose of the Study:

  • To evaluate strategies for reducing pertussis spread and protecting vulnerable infants.
  • To compare the cost-effectiveness of cocooning versus maternal immunization for infant protection.
  • To emphasize the importance of ongoing immunization efforts in children and adults.

Main Methods:

  • Review and synthesis of existing studies comparing different pertussis prevention strategies.
  • Analysis of cost-benefit data for cocooning (immunizing close contacts) versus vaccinating pregnant women.
  • Examination of transmission routes, particularly identifying family members as common sources of infant infection.

Main Results:

  • Maternal immunization during pregnancy demonstrates favorable cost-benefit outcomes compared to cocooning.
  • This strategy is projected to significantly reduce pertussis cases, hospitalizations, and fatalities in infants under one year old.
  • Family members are frequently the source of pertussis infection in infants.

Conclusions:

  • Immunizing pregnant women is a highly effective and cost-efficient public health intervention against pertussis in infants.
  • Sustained efforts to immunize pregnant women, children, and adults are essential for controlling pertussis.
  • Protecting the youngest and most vulnerable populations requires robust and targeted vaccination programs.